https://healthcarenewsnetherlands.com/article/915373731-intravacc-erh-lt-genehmigung-der-franz-sischen-cir-zur-unterst-tzung-von-partnerschaften-in-der-impfstoffforschung-und-entwicklung Healthcare News Netherlands en PressRelease 2026-05-27T06:00:00+00:00 Intravacc erhält Genehmigung der französischen CIR zur Unterstützung von Partnerschaften in der Impfstoffforschung und -entwicklung https://ml-eu.globenewswire.com/media/98e329ff-b497-42cb-af3f-2a8a8d3c799e/small/intravacc-logo-2024-png.png https://healthcarenewsnetherlands.com/article/915373732-intravacc-secures-french-cir-approval-to-support-vaccine-r-d-partnerships Healthcare News Netherlands en PressRelease 2026-05-27T06:00:00+00:00 Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships https://ml-eu.globenewswire.com/media/98e329ff-b497-42cb-af3f-2a8a8d3c799e/small/intravacc-logo-2024-png.png https://healthcarenewsnetherlands.com/article/915373737-intravacc-obtient-l-agr-ment-cir-en-france-pour-accompagner-ses-partenariats-en-r-d-vaccinale Healthcare News Netherlands en PressRelease 2026-05-27T06:00:00+00:00 Intravacc obtient l’agrément CIR en France pour accompagner ses partenariats en R&D vaccinale https://ml-eu.globenewswire.com/media/98e329ff-b497-42cb-af3f-2a8a8d3c799e/small/intravacc-logo-2024-png.png https://healthcarenewsnetherlands.com/article/915107344-onward-medical-reports-first-quarter-2026-results-with-strong-commercial-momentum-and-key-clinical-milestones Healthcare News Netherlands en PressRelease 2026-05-26T05:30:00+00:00 ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png